143 related articles for article (PubMed ID: 3145283)
1. Altered artery mechanics and structure in monocrotaline pulmonary hypertension.
Langleben D; Szarek JL; Coflesky JT; Jones RC; Reid LM; Evans JN
J Appl Physiol (1985); 1988 Nov; 65(5):2326-31. PubMed ID: 3145283
[TBL] [Abstract][Full Text] [Related]
2. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
Altiere RJ; Olson JW; Gillespie MN
J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
[TBL] [Abstract][Full Text] [Related]
3. Ca2(+)-induced contraction and hyperreactivity of pulmonary arterial smooth muscle in monocrotaline-treated rats.
Takenaka T; Ogawa Y; Tobise K
Jpn Circ J; 1990 May; 54(5):515-23. PubMed ID: 2122039
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
Mathew R; Gloster ES; Altura BT; Altura BM
Microcirc Endothelium Lymphatics; 1990; 6(4-5):267-83. PubMed ID: 2149161
[TBL] [Abstract][Full Text] [Related]
5. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension.
Rosenberg HC; Rabinovitch M
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1484-91. PubMed ID: 3144186
[TBL] [Abstract][Full Text] [Related]
6. Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats.
Wilson DW; Segall HJ; Pan LC; Dunston SK
Microvasc Res; 1989 Jul; 38(1):57-80. PubMed ID: 2503687
[TBL] [Abstract][Full Text] [Related]
7. Changes in main pulmonary artery of rats with monocrotaline-induced pulmonary hypertension.
Guzowski DE; Salgado ED
Arch Pathol Lab Med; 1987 Aug; 111(8):741-5. PubMed ID: 3115224
[TBL] [Abstract][Full Text] [Related]
8. Mechanical properties and structure of isolated pulmonary arteries remodeled by chronic hyperoxia.
Coflesky JT; Jones RC; Reid LM; Evans JN
Am Rev Respir Dis; 1987 Aug; 136(2):388-94. PubMed ID: 3619198
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
10. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
Orlinska U; Olson JW; Gillespie MN
Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
[TBL] [Abstract][Full Text] [Related]
11. Changes in alpha(1)-adrenergic vascular reactivity in monocrotaline-treated rats.
Dhein S; Giessler C; Heinroth-Hoffmann I; Leineweber K; Seyfarth T; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):87-95. PubMed ID: 11819025
[TBL] [Abstract][Full Text] [Related]
12. Ventilatory dysfunction precedes pulmonary vascular changes in monocrotaline-treated rats.
Lai YL; Olson JW; Gillespie MN
J Appl Physiol (1985); 1991 Feb; 70(2):561-6. PubMed ID: 1902454
[TBL] [Abstract][Full Text] [Related]
13. Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension.
Wanstall JC; O'Donnell SR
Eur J Pharmacol; 1990 Feb; 176(2):159-68. PubMed ID: 2107090
[TBL] [Abstract][Full Text] [Related]
14. Effect of verapamil on monocrotaline-induced pulmonary artery hypertension and endothelial cell dysfunction in rats.
Mathew R; Guzowski DE; Gloster ES
Exp Lung Res; 1990; 16(6):627-44. PubMed ID: 1964410
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.
van Suylen RJ; Smits JF; Daemen MJ
Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1423-8. PubMed ID: 9603118
[TBL] [Abstract][Full Text] [Related]
16. Magnesium aspartate hydrochloride attenuates monocrotaline-induced pulmonary artery hypertension in rats.
Mathew R; Gloster ES; Altura BT; Altura BM
Clin Sci (Lond); 1988 Dec; 75(6):661-7. PubMed ID: 2974771
[TBL] [Abstract][Full Text] [Related]
17. Altered function of pulmonary endothelium following monocrotaline-induced lung vascular injury in rats.
Ito K; Nakashima T; Murakami K; Murakami T
Br J Pharmacol; 1988 Aug; 94(4):1175-83. PubMed ID: 3145089
[TBL] [Abstract][Full Text] [Related]
18. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
Zhang MF; Liu XR; Yang N; Lin MJ
Sheng Li Xue Bao; 2010 Feb; 62(1):55-62. PubMed ID: 20179889
[TBL] [Abstract][Full Text] [Related]
19. Progesterone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension in estrogen-deficient rats.
Tofovic PS; Zhang X; Petrusevska G
Prilozi; 2009 Jul; 30(1):25-44. PubMed ID: 19736529
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
